Boeing preferred bidder in second India helicopter deal - source
NEW DELHI (Reuters) - India has chosen Boeing Corp (BA.N) as the preferred bidder to supply 15 heavy lift helicopters for its Air Force, a Defence Ministry source said on Monday, potentially the second major Indian contract this year for the Seattle-based firm.
Boeing's Chinook twin rotor helicopters emerged as the lowest bidder and will now hold exclusive negotiations with the ministry, the source told Reuters, speaking on condition of anonymity.
"Depending on how things progress, the final announcement will take three to six months," said the source, who did not give details of the value of the deal.
In Indian defence deals, exclusive talks are not a guarantee of sale.
Earlier this year Boeing's Apache was chosen as the preferred bidder for a deal to provide 22 heavy combat helicopters to India. It was up against Russian Mi-28.
Sections of the media have reported the heavy lift helicopter deal to be valued at $1 billion, and the combat helicopter deal at $1.4 billion.
The Chinook's competitor in the Indian bid was the Russian Mil Moscow Helicopter Plant's Mi-26.
Boeing is also supplying P-8 maritime surveillance planes and C-17 cargo aircraft to the world's largest arms importer.
India has been a big buyer of Soviet Union weaponry and still relies on Russia for 60 percent of its arms purchases, but has diversified its suppliers in recent years. Israel is now the No. 2 seller, with countries like the United States and France also increasing their presence. (Reporting by Arup Roychoudhury; editing by Patrick Graham)
- Tweet this
- Share this
- Digg this
- Microsoft names next operating system 'Windows 10'
- Exclusive - India set to run out of critical free drug for HIV/AIDS programme
- Column: Why work with Modi? It’s the economy, stupid
- Obama, Modi work to deepen improving U.S.-India ties
- Hong Kong democracy protesters and officials mark uneasy National Day
India could run out of a critical medicine in its free HIV/AIDS drugs programme in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month. Full Article